Litcius/Paper detail

Incidence of COVID-19 in a cohort of adult and paediatric patients with rheumatic diseases treated with targeted biologic and synthetic disease-modifying anti-rheumatic drugs

Xabier Michelena, Helena Borrell, Mireia López-Corbeto, María López‐Lasanta, E. Moreno, María Pascual-Pastor, Alba Erra, Mayte Serrat, E. Espartal, Susana Antón, Gustavo Añez Sturchio, Raquel Caparrós-Ruiz, Andrea Pluma, Ernesto Trallero‐Araguás, Mireia Barceló Bru, Míriam Almirall, Juan José de Agustín, Jordi Lladós, Antonio Julià, Sara Marsal

2020Seminars in Arthritis and Rheumatism151 citationsDOIOpen Access PDF

Topics & Concepts

MedicineRheumatic diseaseIncidence (geometry)Coronavirus disease 2019 (COVID-19)HydroxychloroquineCohortDisease2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)PediatricsInternal medicineVirologyInfectious disease (medical specialty)OutbreakOpticsPhysicsRheumatoid Arthritis Research and TherapiesAutoimmune and Inflammatory Disorders ResearchCOVID-19 Clinical Research Studies
Incidence of COVID-19 in a cohort of adult and paediatric patients with rheumatic diseases treated with targeted biologic and synthetic disease-modifying anti-rheumatic drugs | Litcius